StarMed Healthcare is seeking children to participate in Moderna vaccine clinical trial

Share on facebook
Share on twitter

Kids ages 6 months to 5 years old will help study COVID-19 vaccine’s effect on younger ages.

StarMed Healthcare’s east Charlotte urgent care facility

Charlotte, NC (November 17, 2021) – StarMed Healthcare is seeking children between the ages of 6 months and 5 years old to participate in the Moderna KidCOVE COVID-19 vaccine study. The testing is to study the vaccine’s safety and efficacy for children and prevent the spread of COVID-19 in young ages.

Study participants’ compensation for travel and time can range from $1,500 to $2,000 for similar studies. The study does include the possibility of receiving a placebo. Clinical research studies are conducted by doctors and researchers who follow strict guidelines to ensure the safety of the study volunteers who participate.

Participants must:

  • Be between the ages of 6 months and 5 years old
  • Be in good health

Participants must not:

  • Have received an investigational or approved vaccine for COVID-19
  • Be currently taking any investigational or approved treatments for COVID-19
  • Have tested positive for COVID-19 or been in contact with anyone diagnosed with COVID-19 within two weeks prior to vaccine administration
  • Have participated in another COVID-19 trial in the past month

StarMed Healthcare has been involved in proving the safety and effectiveness of medications ranging from diabetes care to meningitis prevention to COVID-19 treatments. StarMed’s experienced research team helps participants feel confidence in the safety and success of the trials.

Parents who are interested and want to register their child can do so at starmed.care/moderna-kids. Some commonly asked questions about clinical trials are here.

StarMed Healthcare is valued on accessible modern facilities, trusted and professional healthcare, and diversity and affordability. It offers community-focused, fully equipped urgent care centers and family medicine practice.